Halozyme Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HALO and other ETFs, options, and stocks.

About HALO

Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence.

CEO

Helen I. Torley

CEOHelen I. Torley

Employees

423

Employees423

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1998

Founded1998

Employees

423

Employees423

HALO Key Statistics

Market cap

7.55B

Market cap7.55B

Price-Earnings ratio

25.47

Price-Earnings ratio25.47

Dividend yield

—

Dividend yield—

Average volume

1.50M

Average volume1.50M

High today

$64.74

High today$64.74

Low today

$63.30

Low today$63.30

Open price

$64.57

Open price$64.57

Volume

317.85K

Volume317.85K

52 Week high

$82.22

52 Week high$82.22

52 Week low

$47.50

52 Week low$47.50

Stock Snapshot

The current Halozyme Therapeutics(HALO) stock price is $63.99, with a market capitalization of 7.55B. The stock trades at a price-to-earnings (P/E) ratio of 25.47.

On 2026-03-18, Halozyme Therapeutics(HALO) stock moved within a range of $63.30 to $64.74. With shares now at $63.99, the stock is trading +1.1% above its intraday low and -1.2% below the session's peak.

Trading activity shows a volume of 317.85K, compared to an average daily volume of 1.5M.

The stock's 52-week range extends from a low of $47.50 to a high of $82.22.

HALO News

Simply Wall St 2d

Could Halozyme Returning David Ramsay as Interim CFO Reframe Its ENHANZE Royalty Story?

Halozyme Therapeutics has appointed David Ramsay as interim Chief Financial Officer, effective March 23, 2026, tasking him with overseeing all financial operati...

Simply Wall St 5d

Halozyme Therapeutics Valuation Check After Recent Share Price Pullback

Advertisement Why Halozyme Therapeutics (HALO) is on investors’ radar today Recent trading in Halozyme Therapeutics (HALO) has drawn attention, with the stock...

Nasdaq 6d

Halozyme Appoints David Ramsay As Interim CFO

(RTTNews) - Halozyme Therapeutics Inc. (HALO), on Thursday, appointed David Ramsay as interim chief financial officer, effective March 23. Ramsay previously se...

Analyst ratings

56%

of 9 ratings

Buy

55.6%

Hold

33.3%

Sell

11.1%

People also own

Based on the portfolios of people who own HALO. This list is generated using Robinhood data, and it’s not a recommendation.

Newmont

Thermo Fisher Scientific

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.